ST6GAL1 and neoplasm: Subcutaneous tumor growth was suppressed effectively in mice treated with ST6Gal-I-shRNA + DDP (149 ± 13 mm3, P < 0.05, Fig. 6c), suggesting that the presence of ST6Gal-I-shRNA enhanced the effect of DDP on the inhibition of tumor growth.